June 25 - Kymera’s new deal, Elevidys under investigation and drug pricing hints from Oz

FDA investigating Elevidys safety; Nektar shares spike on eczema data; Kymera adds Gilead as research partner, while advancing new candidate with Sanofi; Hundreds of laid-off HHS staff have been reinstated, RFK Jr. says; Lexeo to help launch spinout around RNA drugs for the heart

View online | Signup

Daily Dive

June 25, 2025 | Today’s news and insights for biopharma leaders

BROUGHT TO YOU BY — McKesson Compile

Discover where NPs and PAs specialize in oncology

Go beyond the limits of taxonomy codes. New data spotlights the NPs and PAs treating cancer patients in leading U.S. health systems. Download for free.

Oz hints at impending CMS rule to force drug price transparency

The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug cost information, Oz said.

News roundup

FDA investigating Elevidys safety; Nektar shares spike on eczema data

The agency said it will evaluate whether regulatory action is needed after investigating the deaths of two patients treated with Sarepta's therapy.

Kymera adds Gilead as research partner, while advancing new candidate with Sanofi

The biotech will work on molecular glue degraders with Gilead in a new deal. Existing partner Sanofi changed its focus to a new drug prospect, meanwhile.

The rise of GLP-1 drugs: Transforming weight loss treatment

Discover how GLP-1 drugs are reshaping weight loss and treatment horizons.

Hundreds of laid-off HHS staff have been reinstated, RFK Jr. says

HHS rehired more than 700 workers at the CDC and over 200 employees at the NIH after restructuring this spring, HHS Secretary Robert F. Kennedy Jr. told lawmakers Tuesday.

Lexeo to help launch spinout around RNA drugs for the heart

Backed by Perceptive Xontogeny Venture Funds and venBio Partners, the new biotech will make genetic medicines that don’t rely on viral vectors.

Building a Patient-Focused Brand in a Competitive Market

In today’s competitive pharmaceutical market, creative omnichannel campaigns help brands stand out amid complex regulations. Discover how to innovate strategies to drive growth in this playbook.

Download Now

From Our Library

Playbook